serw-MX  [xml]  

 DeCS Categories

A07 Cardiovascular System .
A07.231 Blood Vessels .
A07.231.114 Arteries .
A07.231.114.056 Aorta .
A08 Nervous System .
A08.186 Central Nervous System .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.100 Amino Alcohols .
D02.033.100.291 Ethanolamines .
D02. Epinephrine .
D02.092 Amines .
D02.092.063 Amino Alcohols .
D02.092.063.291 Ethanolamines .
D02. Epinephrine .
D02.092.211 Biogenic Amines .
D02.092.211.215 Biogenic Monoamines .
D02. Catecholamines .
D02. Epinephrine .
D02.092.311 Catecholamines .
D02.092.311.461 Epinephrine .
D10 Lipids .
D10.251 Fatty Acids .
D10.251.355 Fatty Acids, Unsaturated .
D10.251.355.255 Eicosanoids .
D10.251.355.255.100 Arachidonic Acids .
D10.251.355.255.100.450 Leukotrienes .
D10.251.355.310 Fatty Acids, Essential .
D10.251.355.310.166 Arachidonic Acids .
D10.251.355.310.166.887 Leukotrienes .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.456 Oligopeptides .
D12.644.456.345 Dipeptides .
D12.644.456.345.360 Enalapril .
D12.644.456.345.360.300 Enalaprilat .
D12.644.456.345.600 Lisinopril .
D12.776 Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.750 Receptors, Cell Surface .
D12.776.543.750.695 Receptors, G-Protein-Coupled .
D12.776.543.750.695.047 Receptors, Angiotensin .
D12.776.543.750.695.047.625 Receptor, Angiotensin, Type 1 .
D12.776.543.750.750 Receptors, Peptide .
D12.776.543.750.750.130 Receptors, Angiotensin .
D12.776.543.750.750.130.750 Receptor, Angiotensin, Type 1 .
D23 Biological Factors .
D23.469 Inflammation Mediators .
D23.469.050 Autacoids .
D23.469.050.175 Eicosanoids .
D23.469.050.175.450 Leukotrienes .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.085 Angiotensin-Converting Enzyme Inhibitors .
D27.505.519.389.745.085.500 Vasopeptidase Inhibitors .
Z01 Geographic Locations .
Z01.107 Americas .
Z01.107.567 North America .
Z01.107.567.875 United States .
Z01.107.567.875.550 New England .
Z01.107.567.875.550.500 Maine .
 Synonyms & Historicals
Angiotensin-Converting Enzyme Inhibitors .
Angiotensin I-Converting Enzyme Inhibitors .
Angiotensin-Converting Enzyme Antagonists .
Antagonists, Angiotensin-Converting Enzyme .
Antagonists, Kininase II .
Inhibitors, ACE .
Inhibitors, Angiotensin-Converting Enzyme .
Inhibitors, Kininase II .
Kininase II Antagonists .
Angiotensin Converting Enzyme Antagonists .
Angiotensin Converting Enzyme Inhibitors .
Angiotensin I Converting Enzyme Inhibitors .
Antagonists, Angiotensin Converting Enzyme .
Enzyme Antagonists, Angiotensin-Converting .
Enzyme Inhibitors, Angiotensin-Converting .
Inhibitors, Angiotensin Converting Enzyme .
Kininase II Inhibitors .
ACE Inhibitors .
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. .
Enalaprilat .
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate .
Enalaprilat Anhydrous .
Enalaprilat Citrate, Anhydrous .
Enalaprilat Dihydrate .
Enalaprilat, (R)-Isomer, Anhydrous .
MK-422 .
Pres iv .
Vasotec .
Xanef .
Anhydrous Enalaprilat Citrate .
Anhydrous, Enalaprilat .
Dihydrate, Enalaprilat .
MK 422 .
MK422 .
Enalaprilic Acid .
MK-422 .
The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion. .
Vasopeptidase Inhibitors .
ACE-NEP Inhibitors .
NEP-ACE Inhibitors .
ACE NEP Inhibitors .
NEP ACE Inhibitors .
A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II. .
Receptor, Angiotensin, Type 1 .
Angiotensin AT1 Receptor .
Angiotensin AT1a Receptor .
Angiotensin AT1b Receptor .
Angiotensin II Type 1a Receptor .
Angiotensin II Type 1b Receptor .
Receptor, Angiotensin II Type 1 .
Receptor, Angiotensin II Type 1a .
Receptor, Angiotensin II Type 1b .
AT1 Receptor, Angiotensin .
AT1a Receptor, Angiotensin .
AT1b Receptor, Angiotensin .
Receptor, Angiotensin AT1 .
Receptor, Angiotensin AT1a .
Receptor, Angiotensin AT1b .
Angiotensin II Type 1 Receptor .
Angiotensin Type 1 Receptor .
Angiotensin Type 1a Receptor .
Angiotensin Type 1b Receptor .
Receptor, Angiotensin, Type 1a .
Receptor, Angiotensin, Type 1b .
An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention. .
Aorta .
Ascending Aorta .
Aortas .
Aortas, Ascending .
Ascending Aortas .
Aorta, Ascending .
The main trunk of the systemic arteries. .
Central Nervous System .
Cerebrospinal Axis .
Axi, Cerebrospinal .
Axis, Cerebrospinal .
Central Nervous Systems .
Cerebrospinal Axi .
Nervous System, Central .
Nervous Systems, Central .
System, Central Nervous .
Systems, Central Nervous .
The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. .
Epinephrine .
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol .
Adrenaline Acid Tartrate .
Adrenaline Bitartrate .
Adrenaline Hydrochloride .
Epifrin .
Epinephrine Acetate .
Epinephrine Bitartrate .
Epinephrine Hydrochloride .
Epinephrine Hydrogen Tartrate .
Epitrate .
Lyophrin .
Medihaler-Epi .
Acetate, Epinephrine .
Adrenaline .
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. .
Maine .
A state bounded on the east by the Atlantic Ocean, on the north by Canada, and on the south and west by New Hampshire. .
Lisinopril .
Lisinopril Maleate (1:1) .
Lisinopril Sulfate (1:2) .
Lysinopril .
MK-521 .
Prinivil .
Zestril .
One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. .
Leukotrienes .
A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. .